Company Filing History:
Years Active: 2014-2021
Title: The Innovative Contributions of Daniel Lawton
Introduction
Daniel Lawton is a notable inventor based in Bayside, Wisconsin, who has made significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, Lawton's work focuses on developing novel compounds that have the potential to treat various diseases and conditions.
Latest Patents
Among his latest patents are the substituted N-acetyl-L-cysteine derivatives and related compounds. These innovative compounds are designed for the treatment of diseases involving the Central Nervous System (CNS). The conditions addressed by these compounds include schizophrenia, adrenoleukodystrophy, mitochondrial diseases such as Leigh syndrome, Alpers' disease, and MELAS, as well as Huntington's disease, trichotillomania, HIV-associated neurocognitive disorder, hypoxic-ischemic encephalopathy, drug craving, and drug addiction.
Career Highlights
Daniel Lawton is currently associated with Promentis Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic options for patients suffering from complex neurological conditions.
Collaborations
Lawton collaborates with esteemed colleagues, including Michael Neary and James Nieman, to further enhance the impact of his research. Their combined expertise contributes to the innovative environment at Promentis Pharmaceuticals.
Conclusion
Daniel Lawton's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts highlight his dedication to advancing medical science. His work has the potential to significantly improve the lives of individuals affected by challenging health conditions.